ARCS Forward - Neurological Diseases
Tuesday, May 10, 2022, at 12:00 PM ET/11:00 AM CT/10:00 AM MT/9:00 AM PT/7:00 AM HT
ARCS Forward events are personal and intimate conversations between members, current scholars, and other outstanding scientists in all STEM fields. These events are held virtually over Zoom. This month's speakers are ARCS Scholars Amanda McQuade (Orange County) and Chantel Charlebois (Utah). This event will be moderated by Kathern Plenge, retired neurologist.
Chantel Charlebois is a fifth-year National Science Foundation Graduate Research Fellow in Biomedical Engineering at the University of Utah. Her research aims to better understand the mechanisms of neurostimulation to treat epilepsy and improve this therapy to provide better seizure control. She uses computational models, neuroimaging, and clinical data to identify why some patients respond to therapy and others do not. Chantel is passionate about promoting diversity and inclusion in STEM and is co-president of the Graduate Women in Biomedical Engineering organization at the University of Utah.
Amanda McQuade earned her B.A. in Cellular and Molecular Neuroscience in 2016 from Scripps College in Claremont, California. For her graduate studies she joined the lab of Dr. Mathew Blurton-Jones at the University of California, Irvine to study genetic risk factors for Alzheimer’s disease (AD). Amanda discovered that decreased immune activation leads to higher risk of AD. This suggests that specific avenues of immune activation may be beneficial to help patients fight AD. For this work, she was awarded a T32 training program in stem cell translational medicine for neurological disorders as well as a prestigious ARCS foundation scholarship. Throughout her time at UCI, she published 5 first-author manuscripts and took part in numerous collaborative projects. Amanda also became interested in outreach and education. She served as a co-chair for Research and Education through UCI MIND for 3 years and was a founding mentor for Brain Explorer’s camp through the Center for the Neurobiology of Learning and Memory. After defending her thesis in September 2021, Amanda has moved to UCSF to pursue a postdoctoral fellowship in the lab of Dr. Martin Kampmann. Her postdoctoral studies are focused on using CRISPR-based functional genomic platforms to interrogate driving factors of immune activation states associated with neurodegenerative disease